Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

BACKGROUND: Annual MRI screening is associated with a significant reduction in advanced-stage breast cancer diagnosis in BRCA1/2 mutation carriers. The impact that early detection has on subsequent oncological treatment is less frequently reported. In this study we compared disease stage and therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstein-Molho, Rinat, Kaufman, Bella, Ben David, Merav A., Sklair-Levy, Miri, Feldman, Dana Madoursky, Zippel, Dov, Laitman, Yael, Friedman, Eitan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375664/
https://www.ncbi.nlm.nih.gov/pubmed/31760168
http://dx.doi.org/10.1016/j.breast.2019.10.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375664/
https://www.ncbi.nlm.nih.gov/pubmed/31760168
http://dx.doi.org/10.1016/j.breast.2019.10.012

Ejemplares similares